期刊文献+

西地那非对新生儿肺动脉高压患儿血浆细胞因子的影响及疗效研究 被引量:1

Effect of Sildenafil on plasma cytokines for pulmonary arterial hypertension newborns
下载PDF
导出
摘要 目的探讨西地那非对新生儿肺动脉高压患儿血浆细胞因子的影响。方法选择2013年1月~2018年5月在我院治疗的肺动脉高压患儿84例,按照随机数字表法分为对照组与观察组各42例。对照组给予常规治疗,观察组在常规治疗上加用西地那非治疗,观察比较两组患儿的疗效以及治疗前后血浆细胞因子BNP、NT-proBNP水平及Ca^2+水平变化。结果观察组的总有效率明显高于对照组,差异有统计学意义(P<0.05)。两组治疗后的BNP、NT-proBNP、Ca^2+水平均较治疗前明显改善,而观察组各指标水平改善明显优于对照组,差异均有统计学意义(P<0.05)。结论西地那非治疗新生儿肺动脉高压的效果显著,能有效改善患儿血浆细胞因子指标,安全性较好,值得推广。 Objective To discuss the influence of Sildenafil on plasma cytokines for pulmonary arterial hypertension newborns.Methods 84 newborns with pulmonary arterial hypertension(2013.01-2018.05)in our hospital were chosen and randomly assigned to two groups,42 cases in each group.The control group took the routine therapy;on the basis of the former,the test group took Sildenafil.The curative effect and plasma cytokine levels were compared.Results The total effective rate in the test group was higher than control group;after treatment,BNP(brain natriuretic peptide)and NT-proBNP(N-terminal pro-brain natriuretic peptide)levels in the test group were lower than control group;Ca^2+levels were higher than control group(P<0.05).Conclusion Sildenafil has obvious effects in pulmonary arterial hypertension newborns,which can efficiently improve the plasma cytokines and treatment safety.
作者 杨敏继 YANG Min-ji(People's Hospital of Baise,Baise,Guangxi,533000,China)
机构地区 百色市人民医院
出处 《蛇志》 2020年第2期188-189,共2页 Journal of Snake
关键词 西地那非 新生儿 肺动脉高压 血浆细胞因子 Sildenafil newborns pulmonary arterial hypertension plasma cytokines
  • 相关文献

参考文献5

二级参考文献47

  • 1曾嵘,庄建,岑坚正,陈欣欣,熊卫萍,朱卫中.枸橼酸西地那非治疗心脏手术后肺动脉高压的临床研究[J].中华心血管病杂志,2005,33(10):916-919. 被引量:28
  • 2汤慧芳,毛连根,何威,汪雪峰,谢强敏,陈季强.西地那非对脂多糖诱导的小鼠急性肺损伤的作用[J].中国药理学与毒理学杂志,2007,21(4):259-264. 被引量:5
  • 3金汉珍,黄德珉,官希吉.实用新生儿学[M].4版.北京:人民卫生出版社,2010:425-430.
  • 4ATYINO T M, MALATINO L S, MAXWELL S R, et al. Ph- osphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatationin hypertensive patients [ J ]. Hypertension, 2008,26 ( 3 ) : 501-507.
  • 5SHEKERDEMIAN L S, RAVN H B, PENNY D J. Intrav- enous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension[ J ]. Am J Respir Crit Care M ed, 2002,165 ( 8 ) : 1098-1102.
  • 6GALIE N, GHOFRANI H A, TORBICKI A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension [ J ]. N Engl J Med,2005,353(20):2148-2157.
  • 7KARATZA A A, NARANG I, ROSENTHAL M, et al. Treat- ment of primary pulmonary hypertension with oral sildenafil E J ]. Respiration, 2004,71 ( 2 ) : 192-194.
  • 8KARATZA A A, NARANG I, ROSENTHAL M, et al. Treat- ment of primary pulmonary hypertension with oral sildenafil [ J ]. Respiration, 2004,71 ( 2 ) : 192-194.
  • 9黄学荪,刘金来,王志强.枸橼酸西地那非临床应用新进展[J].海峡药学,2008,20(4):77-78. 被引量:8
  • 10李源斌,王文祥,陆妹,王爱平.米力农治疗新生儿持续肺动脉高压临床观察[J].临床医学工程,2010,17(8):103-105. 被引量:6

共引文献51

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部